This financial performance reflects the company's robust growth in key areas such as oncology and vaccines. Sales for the ...

Regulatory news last week saw the US Food and Drug Administration (FDA) make a land-mark decision to approve the first gene therapies ... Switzerland’s Basilea Pharmaceutica entered into an asset ...

Solvias is building out a 50,000-square-foot facility that will expand its analytical testing services for companies developing cell and gene therapies and ... general manager of U.S. operations, said ...

The first-quarter 2024 earnings season is almost over as far as large drugmakers are concerned. Eli Lilly LLY, Novo Nordisk ...

Previously approved as a second-line treatment in 2015, following Pfizer’s Xalkori (crizotinib) for metastatic ALK-positive ...

Pfizer's groundbreaking $3.5 million gene therapy for Hemophilia B just got FDA approval. Here’s what it means for patients ...

The US Food and Drug Administration (FDA) on Friday approved Padcev (enfortumab vedotin-ejfv, an antibody-drug conjugate [ADC]) with Keytruda (pembrolizumab, a PD-1 inhibitor) for the treatment of ...

ETHealthworld.com brings latest healthcare news, views and updates. Get healthcare industry & sector news from all top sources for the Indian Health industry.